Weekly Watchlist! Here come some

New Post Public Reply Private Reply Replies (0) Message Board
ruliquid

Weekly Watchlist! Here come some Runners...

http://huntforthenext10bagger.com/watch-list

~As the dog days of Summer come to an end and we welcome the first day of Fall we expect OTC volume to kick in once again. Summer was good especially compared to last year BUT September was usually slow. October?
We had some great runs over the Summer in the OTC with CBYI, SKTO, TCPS, MYEC, BRND, PMCM, MINE & NTEK to name a few.
We are starting this week with a few bottom plays which we feel are RIPE for another run!
Please continue to check our webpage for daily updates:
http://huntforthenext10bagger.com/

Lets have a huge week! Good Luck -Ruliquid

***Dollar volume continues strong, way over last year! Massive peak in May. Still very strong in June, July, August! September did seem unusually slow…

This Week’s U.S. Economic Calendar
Economic Calendar: http://huntforthenext10bagger.com/economic-calendar


Bottom Plays & Scans on radar this week!


Momentum Play ILIV $ 0.0018 ?-0.0001 (-5.26%)
ILIV new name, new symbol, new direction. Now it’s time for accelerated growth and price appreciation! Along with this new direction comes a commitment for expedited revenue, profitability and increased shareholder value.
Watch for ILIV to be very active this week coming off bottom and rumored Press could accelerate this volume! Breaks .0024 resistance it goes!

Website: http://www.intelligentlivinginc.com/
http://www.mind360.com/

http://stockcharts.com/h-sc/ui?s=iliv


Bottom Play PTOG
$ 0.017 ? -0.0025 (-12.82%) is one to watch for buying opportunities in the mid .01?s here.
Huge Recent News:
PetroTech Oil and Gas Announces $800,000 LOI for Bartlesville, Barbee/Brown Lease (Oklahoma) 240 Acres, 26 Wells
http://finance.yahoo.com/news/petrotech-oil-g...00337.html

Check out PTOG New Online Magazine for more DD: http://www.johnnyrichardson.com/petrotech/petro.html

PTOG was trading over .10+ in June


Website: http://petrotechog.com/

http://stockcharts.com/h-sc/ui?s=PTOG


Undervalued Play LTNC $ 0.26 ? 0.00 (0.00%) LTNC recent Huge News: Labor SMART, Inc. Monthly Revenue Exceeds $2 Million
Year-to-Date Revenues Exceed $10,237,056
HIRAM, GA–(Marketwired – Sep 5, 2013) – Labor SMART, Inc. OTCQB: LTNC) (the “Company”) is pleased to report its strongest month to date with $2,109,383 in revenue for the month of August 2013. This compares to revenues of $765,548 in August 2012 constituting a 175% increase in revenues over the same month prior year.
August represents the first month where the Company has exceeded over two million dollars in revenues in a single month. Additionally, the Company announced that Year-to-Date revenues have exceeded $10 million for the first eight months of 2013.
The last 90 days have also shown incremental revenue increases of 44.96% with the same 14 branches as they continue to mature while expanding their client base. http://finance.yahoo.com/news/labor-smart-inc...00048.html

So keep LTNC on radar for continued growth & updates!


Website: http://www.laborsmart.com/

http://stockcharts.com/h-sc/ui?s=ltnc


Momentum Trading Play CBYI $ 0.0015 ? -0.0004 (-21.05%)
At this point most traders have heard or played CBYI.
CBYI ran from a low of .0001 to .0049 in 7 days. Since then has been trading from .001?s to .002?s almost daily. Love it or hate it CBYI provides many trading opportunities as investors wait for the next move!


Website: http://www.cambertire.com/

http://stockcharts.com/h-sc/ui?s=cbyi


Chart Speculation Play TCPS $ 0.0087 ? 0.00 (0.00%) We have played TCPS many times in the past for huge gains! Rumored PR’s and push this week. Breaks .012 :could” go hard.
http://stockcharts.com/h-sc/ui?s=tcps


Bottom Play WBSI
$ 0.0018 ?-0.0001 (-5.26%) Major churning over the past few weeks. Rumored much overdue News expected this week.
Could be a nice trade opportunity as well


Website: http://websafety.com/

http://stockcharts.com/h-sc/ui?s=wbsi


Bottom Play IGNT
$ 0.0011 ? 0.00 (0.00%) Some huge news “mostly” missed last week…hearing more upates on the way.

RIVERSIDE, CA–(Marketwired – Sep 19, 2013) – Ingen Technologies Inc. (PINKSHEETS: IGNT) ( http://ingen-tech.com ) announced today that Dave Hanson, one of the pioneers of Viacom and co-creator of “Showtime,” has agreed to join the Ingen Board and work directly with Ingen’s telecom division to direct its initial $25M expansion of existing services and new telecom industry sectors. http://finance.yahoo.com/news/co-creator-show...31645.html


Website: http://ingen-tech.com/

http://stockcharts.com/h-sc/ui?s=ignt

Also possible tickers: TDEY, HVYW, AXCG, LATF, AGEY, LVGI, URHN, VLYF, ACYD, JZHG & FROZ on watch for movement.


Do you have a pick you think is going to go?
Please PM me or email me @ ruliquid@gmail.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 13

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 8

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 10

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 8

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 11

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 6

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 11

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 7

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 13

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Credit Card Interest Rates and How to Manage Them

Updated Category News Views 352

Understanding Credit Card Interest Rates Recently, the average credit card interest rate has climbed to 22.63%, a notable rise from the previous average of 16.98%. The interest rate you face can vary widely based on the type of credit card and your individual credit profile. By understanding how credit card annual percentage rates (APR) work, you can potentially reduce...

Continue Reading
Hexaware Reports Strong Q3CY25 Performance with Revenue Rise

Updated Category News Views 183

Hexaware Technologies Financial Results Overview Hexaware Technologies (NSE: HEXT) has showcased impressive performance for the third quarter of calendar year 2025, with total revenue reaching USD 394.8 million. This figure marks a noteworthy increase of 5.5% year-over-year, showcasing the company's resilience and ability to navigate market challenges effectively....

Continue Reading
Alm. Brand A/S Reports Progress in Share Buybacks for 2024

Updated Category News Views 102

Overview of Alm. Brand A/S Share Buy-Back Program Alm. Brand A/S has kicked off an ambitious share buy-back program, looking to acquire shares totaling up to DKK 150 million. This initiative was officially announced earlier, providing insight into the year's financial strategy. Recent Transactions Under the Program During the week starting 9 September 2024 and ending on...

Continue Reading
NRx Pharmaceuticals Adjusts Release Date for Q2 Financials

Updated Category News Views 158

NRx Pharmaceuticals Announces Rescheduled Q2 2025 Financial Results Release NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) recently made an exciting announcement regarding the release of its second quarter 2025 financial results. The company has decided to delay the publication of these results to ensure a more comprehensive presentation for its stakeholders. This update comes...

Continue Reading
Top 5 Stocks to Watch for a Market Pullback Soon

Updated Category News Views 216

Understanding Market Pullbacks As major U.S. stock indices reached unprecedented levels recently, the optimism surrounding potential Federal Reserve rate cuts has driven prices higher. However, the surge seems excessive given the realistically anticipated modest decrease in rates. This opens a window for investors to reassess their portfolios, particularly those holdings...

Continue Reading